These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 30626087)
1. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells. Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087 [TBL] [Abstract][Full Text] [Related]
2. Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy. Samuel SM; Varghese E; Satheesh NJ; Triggle CR; Büsselberg D Biomed Pharmacother; 2023 Aug; 164():114911. PubMed ID: 37224753 [TBL] [Abstract][Full Text] [Related]
3. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945 [TBL] [Abstract][Full Text] [Related]
4. Glucose promotes breast cancer aggression and reduces metformin efficacy. Wahdan-Alaswad R; Fan Z; Edgerton SM; Liu B; Deng XS; Arnadottir SS; Richer JK; Anderson SM; Thor AD Cell Cycle; 2013 Dec; 12(24):3759-69. PubMed ID: 24107633 [TBL] [Abstract][Full Text] [Related]
5. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus. Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867 [TBL] [Abstract][Full Text] [Related]
6. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966 [TBL] [Abstract][Full Text] [Related]
7. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells. Amaral I; Silva C; Correia-Branco A; Martel F Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639 [TBL] [Abstract][Full Text] [Related]
8. Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness. De P; Sun Y; Carlson JH; Friedman LS; Leyland-Jones BR; Dey N Neoplasia; 2014 Jan; 16(1):43-72. PubMed ID: 24563619 [TBL] [Abstract][Full Text] [Related]
9. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells. Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138 [TBL] [Abstract][Full Text] [Related]
10. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells. Messeha SS; Zarmouh NO; Asiri A; Soliman KFA Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339 [TBL] [Abstract][Full Text] [Related]
11. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA Nutrients; 2022 May; 14(10):. PubMed ID: 35631261 [TBL] [Abstract][Full Text] [Related]
12. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer. Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586 [TBL] [Abstract][Full Text] [Related]
13. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors. Wokoun U; Hellriegel M; Emons G; Gründker C Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075 [TBL] [Abstract][Full Text] [Related]
14. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells. Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100 [TBL] [Abstract][Full Text] [Related]
15. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441 [TBL] [Abstract][Full Text] [Related]
16. Triterpenoid Saponin AG8 from Mu LH; Wang LH; Yu TF; Wang YN; Yan H; Liu P; Yan C Oxid Med Cell Longev; 2020; 2020():7963212. PubMed ID: 33123316 [TBL] [Abstract][Full Text] [Related]
17. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992 [TBL] [Abstract][Full Text] [Related]
18. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells. Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408 [TBL] [Abstract][Full Text] [Related]
19. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions. Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325 [TBL] [Abstract][Full Text] [Related]
20. Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways. Qu Z; Lin Y; Mok DK; Bian Q; Tai WC; Chen S Int J Med Sci; 2020; 17(11):1482-1490. PubMed ID: 32669950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]